{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:07Z","timestamp":1790312407904,"version":"4.1.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The endocannabinoid system (ECS) regulates key processes in energy homeostasis, but its contribution to severe obesity beginning in childhood or adolescence remains incompletely understood. This study aimed to identify rare variants in ECS genes and evaluate their potential structural effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 93 adults with severe obesity beginning before 21 years of age (BMI \u2265 35 kg\/m\u00b2) were recruited from two specialized obesity programs; among participants with onset information, 97.8% reported childhood onset. Whole-exome sequencing was performed, followed by targeted analysis of ECS-related genes. Rare variants (allele frequency &amp;lt;1%) were confirmed by Sanger sequencing and assessed using\n                      <jats:italic>in silico<\/jats:italic>\n                      pathogenicity prediction and molecular modeling.\n                      <jats:italic>In silico<\/jats:italic>\n                      saturation mutagenesis of all 19 possible substitutions at each variant position was additionally performed using three complementary stability predictors based on different methodological principles (FoldX, Pythia and DDMut), together with AlphaMissense.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine rare variants were identified in twelve individuals, seven of which were defined as variants of uncertain significance (VUS). Among the observed variants,\n                      <jats:italic>FAAH<\/jats:italic>\n                      p.(Arg326Pro) showed the most concordant predicted impact: it ranked as the most destabilizing substitution at position 326 by FoldX (\u0394\u0394G = +3.04 kcal\/mol; rank 1 of 19) and was the only observed variant classified as likely pathogenic by AlphaMissense (0.884). Arg326 lies 24.3 \u00c5 from the catalytic triad (Lys142\u2013Ser217\u2013Ser241), consistent with a predicted effect on fold stability rather than direct disruption of the active site. Conversely, at\n                      <jats:italic>DAGLA<\/jats:italic>\n                      position 750, all 19 substitutions were predicted as neutral by FoldX and DDMut and as likely benign by AlphaMissense, consistent with predicted structural tolerance at this position. No anthropometric or metabolic parameter differed significantly between carriers and non-carriers after correction for multiple testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Rare ECS variants, including a previously unreported\n                      <jats:italic>FAAH<\/jats:italic>\n                      p.(Arg326Pro) substitution, were identified in adults with severe obesity, predominantly with childhood onset. These\n                      <jats:italic>in silico<\/jats:italic>\n                      analyses are predictive and provide computational evidence for prioritizing candidate variants, notably\n                      <jats:italic>FAAH<\/jats:italic>\n                      p.(Arg326Pro); they do not, by themselves, establish pathogenicity or a causal relationship with the phenotype, which will require functional validation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1862926","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:27Z","timestamp":1790310447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Rare endocannabinoid system variants identified by whole-exome sequencing and structural modeling in adults with severe obesity predominantly of childhood onset"],"prefix":"10.3389","volume":"17","author":[{"given":"Kaio Cezar Rodrigues","family":"Salum","sequence":"first","affiliation":[{"name":"Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro","place":["Rio de Janeiro, Brazil"]},{"name":"Molecular Genetics Laboratory, Paulo Niemeyer State Institute of the Brain","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritiele Bastos de","family":"Souza","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Laboratory for Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Antunes","sequence":"additional","affiliation":[{"name":"Laboratory for Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izadora Sthephanie da Silva","family":"Assis","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Wendling","family":"Gouv\u00eaa","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrela Ribeiro","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Human Genetics Laboratory, Institute of Biology, Federal Fluminense University","place":["Niter\u00f3i, Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia Alves Figueira de","family":"Melo","sequence":"additional","affiliation":[{"name":"Cellular Microbiology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohanna","family":"Palhinha","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella de Medeiros","family":"Abreu","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Genetics Laboratory, Grande Rio University\/AFYA","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia da Silva","family":"Alves","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Genetics Laboratory, Grande Rio University\/AFYA","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Silva","sequence":"additional","affiliation":[{"name":"Genetics Laboratory, Grande Rio University\/AFYA","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica Marques","family":"Zembrzuski","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Campos Junior","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Menezes","family":"Maya-Monteiro","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Torres","family":"Bozza","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Proen\u00e7a","family":"da Fonseca","sequence":"additional","affiliation":[{"name":"Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation","place":["Rio de Janeiro, Brazil"]},{"name":"Genetics Laboratory, Grande Rio University\/AFYA","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Regis Ivar","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.02.104","article-title":"Obesity pandemic: causes, consequences, and solutions\u2014but do we have the will","volume":"107","author":"Meldrum","year":"2017","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"B4","unstructured":"Obesity\n          \n          \n          Obesity\n          \n          2022"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020373","article-title":"What role does the endocannabinoid system play in the pathogenesis of obesity","volume":"13","author":"Schulz","year":"2021","journal-title":"Nutrients"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106520","article-title":"Understanding the possible role of endocannabinoid system in obesity","volume":"152","author":"Behl","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldx022","article-title":"The contribution of genetics and environment to obesity","volume":"123","author":"Albuquerque","year":"2017","journal-title":"Br Med Bull"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2017.04.026","article-title":"Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies","volume":"31","author":"da Fonseca","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: from discovery to biology","volume":"23","author":"Loos","year":"2022","journal-title":"Nat Rev Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.722441","article-title":"When leptin is not there: A review of what nonsyndromic monogenic obesity cases tell us and the benefits of exogenous leptin","volume":"12","author":"Salum","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.crvi.2016.11.007","article-title":"Molecular genetics of human obesity: A comprehensive review","volume":"340","author":"Singh","year":"2017","journal-title":"CR Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/NU13041214","article-title":"Endocannabinoids and the gut-brain control of food intake and obesity","volume":"13","author":"Di Patrizio","year":"2021","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13504","article-title":"Genetic polymorphisms of the endocannabinoid system in obesity and diabetes","volume":"21","author":"Doris","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-012-0027-6","article-title":"Obesity and the endocannabinoid system: Circulating endocannabinoids and obesity","volume":"1","author":"Matias","year":"2012","journal-title":"Curr Obes Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.07.007","article-title":"The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease","volume":"26","author":"Mazier","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04002-6","article-title":"Hypothalamic endocannabinoids in obesity: an old story with new challenges","volume":"78","author":"Miralpeix","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/MCROCQ","article-title":"History of cannabis and the endocannabinoid system","volume":"22","author":"Crocq","year":"2020","journal-title":"Dialogues Clin Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/365061A0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1017\/S0954422414000080","article-title":"The endocannabinoid system and appetite: relevance for food reward","volume":"27","author":"Jager","year":"2014","journal-title":"Nutr Res Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/J.ORCP.2020.05.007","article-title":"The association of circulating endocannabinoids with appetite regulatory substances in obese women","volume":"14","author":"Lotfi Yagin","year":"2020","journal-title":"Obes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/AJPENDO.00355.2017","article-title":"Endocannabinoids and cannabinoid receptors as regulators of endocrine functions and tissue metabolism: Plasma endocannabinoid levels in lean, overweight, and obese humans: Relationships to intestinal permeability markers, inflammation, and incretin secretion","volume":"315","author":"Little","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2009.04.004","article-title":"The endocannabinoid system: Role in glucose and energy metabolism","volume":"60","author":"Nogueiras","year":"2009","journal-title":"Pharmacol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061279","article-title":"Role of the endocannabinoid system in the adipose tissue with focus on energy metabolism","volume":"10","author":"Rakotoarivelo","year":"2021","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852915000668","article-title":"The role of the opioid system in binge eating disorder","volume":"20","author":"Giuliano","year":"2015","journal-title":"CNS Spectr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2826.2008.01671.X","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2302-6","article-title":"Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice","volume":"54","author":"Bajzer","year":"2011","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR 141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEULET.2007.04.012","article-title":"The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food","volume":"419","author":"Melis","year":"2007","journal-title":"Neurosci Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.9811\/SUPP-1","article-title":"High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or 1(9)-tetrahydrocannabivarin on weight gain","volume":"8","author":"Wargent","year":"2020","journal-title":"PeerJ"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and \u03b2-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1096\/FJ.13-247643","article-title":"Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity","volume":"28","author":"Boon","year":"2014","journal-title":"FASEB J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0008792","article-title":"Biomarkers of endocannabinoid system activation in severe obesity","volume":"5","author":"Sipe","year":"2010","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142728","article-title":"Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture","volume":"11","author":"Martins","year":"2015","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000178157","article-title":"Evaluating the association of FAAH common gene variation with childhood, adult severe obesity and type 2 diabetes in the French population","volume":"1","author":"Durand","year":"2008","journal-title":"Obes Facts"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0201173","article-title":"Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, obesity and dyslipidemia using Meta-CCA and gene-based approach","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/MET.2023.0014","article-title":"FAAH Pro129Thr variant is associated with increased cholesterol levels in normal-weight metabolically unhealthy subjects","volume":"21","author":"Sierra-Ruelas","year":"2023","journal-title":"Metab Syndrome Related Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2523","article-title":"Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men","volume":"92","author":"Russo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/HMG\/DDN089","article-title":"Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations","volume":"17","author":"Benzinou","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0192","article-title":"Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution","volume":"163","author":"Frost","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/039463201002300103","article-title":"Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry","volume":"23","author":"Graham","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.8034","article-title":"Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.826400","article-title":"Expression and functions of the CB2 receptor in human leukocytes","volume":"13","author":"Simard","year":"2022","journal-title":"Front Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005844","article-title":"Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis","volume":"4","author":"Deveaux","year":"2009","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4381","article-title":"Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation","volume":"101","author":"Rossi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.169","article-title":"Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice","volume":"40","author":"Schmitz","year":"2016","journal-title":"Int J Obes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140592","article-title":"Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice","volume":"10","author":"Verty","year":"2015","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118424","article-title":"CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2\/HO-1 pathway in diet-induced obese mice","volume":"260","author":"Wu","year":"2020","journal-title":"Life Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-024-00567-y","article-title":"Updates on rare genetic variants, genetic testing, and gene therapy in individuals with obesity","volume":"13","author":"Zuccaro","year":"2024","journal-title":"Curr Obes Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S189455","article-title":"Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient","volume":"12","author":"da Fonseca","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.608840","article-title":"Identification of a rare and potential pathogenic MC4R variant in a Brazilian patient with adulthood-onset severe obesity","volume":"11","author":"Salum","year":"2020","journal-title":"Front Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/s41467-022-29575-z","article-title":"Whole-genome sequencing of 1,171 elderly admixed individuals from Brazil","volume":"13","author":"Naslavsky","year":"2022","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/nejmsr1406261","article-title":"ClinGen \u2014 The clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJHG.2016.08.016","article-title":"REVEL: An ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad472","article-title":"DDMut: predicting effects of mutations on protein stability using deep learning","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(87)90038-6","article-title":"Interior and surface of monomeric proteins","volume":"196","author":"Miller","year":"1987","journal-title":"J Mol Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAE385","article-title":"AIUPred: combining energy estimation with deep learning for the enhanced prediction of protein disorder","volume":"52","author":"Erdos","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz184","article-title":"FoldX 5.0: working with RNA, small molecules and a new graphical interface","volume":"35","author":"Delgado","year":"2019","journal-title":"Bioinformatics"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100750","article-title":"Structure-based self-supervised learning enables ultrafast protein stability prediction upon mutation","volume":"6","author":"Sun","year":"2025","journal-title":"Innovation"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2011.03.019","article-title":"A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions","volume":"19","author":"Shapovalov","year":"2011","journal-title":"Structure"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"B76","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Stat"},{"key":"B77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Society: Ser B (Methodological)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"B79","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/S41366-023-01428-9","article-title":"Association between the FAAH C385A variant (rs324420) and obesity-related traits: a systematic review","volume":"48","author":"Lopez-Cortes","year":"2024","journal-title":"Int J Obes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/J.PSYNEUEN.2008.01.004","article-title":"The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight\/obesity but not with binge eating disorder in overweight\/obese women","volume":"33","author":"Monteleone","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1261-1","article-title":"Genetic interaction of DGAT2 and FAAH in the development of human obesity","volume":"56","author":"Ning","year":"2017","journal-title":"Endocrine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/J.ENDINU.2017.06.001","article-title":"Polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CNR2) reveals effects on body weight and insulin resistance in obese subjects","volume":"64","author":"de Luis","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.030","article-title":"Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets","volume":"139","author":"de Luis","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/OBY.2010.219","article-title":"A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study)","volume":"19","author":"Wangensteen","year":"2011","journal-title":"Obesity"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-255208","article-title":"N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis","volume":"29","author":"Alhouayek","year":"2015","journal-title":"FASEB J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/PH17081098","article-title":"TRPV1 activation antagonizes high-fat diet-induced obesity at thermoneutrality and enhances UCP-1 transcription via PRDM-16","volume":"17","author":"Baskaran","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00420","article-title":"Involvement of TRPV1 channels in energy homeostasis","volume":"9","author":"Christie","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121316","article-title":"Potential of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), and diacylglycerol lipase (DAGL) enzymes as targets for obesity treatment: A narrative review","volume":"14","author":"Matheson","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-08051-7","article-title":"Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis","volume":"10","author":"Everard","year":"2019","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1038\/NCOMMS7495","article-title":"Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota","volume":"6","author":"Geurts","year":"2015","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000115333","article-title":"Monogenic human obesity","volume":"36","author":"Farooqi","year":"2008","journal-title":"Obes Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1146\/ANNUREV.MED.56.062904.144924","article-title":"Monogenic obesity in humans","volume":"56","author":"Farooqi","year":"2005","journal-title":"Annu Rev Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060640","article-title":"Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-68192-4_8","article-title":"Monogenic obesity","author":"Pigeyre","year":"2018","journal-title":"Contemp Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-022-01506-3","article-title":"SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort","volume":"27","author":"da Fonseca","year":"2022","journal-title":"Eating Weight Disord"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-020-00946-z","article-title":"Study of LEP, MRAP2 and POMC genes as potential causes of severe obesity in Brazilian patients","volume":"26","author":"da Fonseca","year":"2021","journal-title":"Eating Weight Disord"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/S40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/87551225221116010","article-title":"Setmelanotide: A novel targeted treatment for monogenic obesity","volume":"38","author":"Pressley","year":"2022"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-024-01553-z","article-title":"The circulating and central endocannabinoid system in obesity and weight loss","volume":"48","author":"Mattelaer","year":"2024","journal-title":"Int J Obes"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.509","article-title":"The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure","volume":"17","author":"Verty","year":"2009","journal-title":"Obesity"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/PH4081101","article-title":"The endocannabinoid system as pharmacological target derived from its CNS role in energy homeostasis and reward. Applications in eating disorders and addiction","volume":"4","author":"Viveros","year":"2011","journal-title":"Pharmaceuticals"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/EN.2012-1405","article-title":"Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice","volume":"153","author":"Cardinal","year":"2012","journal-title":"Endocrinology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHARMTHERA.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117501","article-title":"New peripherally-restricted CB1 receptor antagonists, PMG-505\u2013010 and -013 ameliorate obesity-associated NAFLD and fibrosis","volume":"180","author":"Yang","year":"2024","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(25)00255-4","article-title":"Peripheral CB1 receptor blockade for treatment of obesity","volume":"13","author":"Gadde","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1021\/ACSPTSCI.1C00048","article-title":"Functional selectivity of a biased cannabinoid-1 receptor (CB1R) antagonist","volume":"4","author":"Liu","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15353","article-title":"Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study","volume":"26","author":"Crater","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(25)00216-5","article-title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Knop","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1862926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:30Z","timestamp":1790310450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1862926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":111,"alternative-id":["10.3389\/fendo.2026.1862926"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1862926","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1862926"}}